BridgeBio Oncology Therapeutics, Inc. — insider transactions

1 transactions on record · BBOT · CIK 1869105

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
1
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$544
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$544
2026-10-21
Director share, 12m
0.0%
of transactions where role is stated
Current run
1 sells
consecutive same-direction transactions
Net 3m flow
-$544
purchases minus sales
Total on record
1

Transactions

1 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-10-232026-10-212Cobo MarcPrincipal Accounting OfficerShares withheld for tax203$2.68$544filing

Source: U.S. Securities and Exchange Commission, EDGAR

BridgeBio Oncology Therapeutics, Inc. insider transactions — 1 filings on record — investment.com